Correction to: Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
Main Authors: | Yvette N. Löwensteyn, Natalie I. Mazur, Harish Nair, Joukje E. Willemsen, Ghislaine van Thiel, Louis Bont, The RSV GOLD III—ICU Network Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | BMC Infectious Diseases |
Online Access: | https://doi.org/10.1186/s12879-021-06671-x |
Similar Items
-
Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
by: Yvette N. Löwensteyn, et al.
Published: (2021-08-01) -
Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries
by: Xiao Li, et al.
Published: (2020-04-01) -
Global molecular diversity of RSV – the “INFORM RSV” study
by: Annefleur C. Langedijk, et al.
Published: (2020-06-01) -
Respiratory syncytial virus (RSV) disease – new data needed to guide future policy
by: Louis Bont, et al.
Published: (2015-12-01) -
Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
by: Maaike Nederend, et al.
Published: (2020-08-01)